A comprehensive view of AstraZeneca AB. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca completes acquisition of Gracell Biotechnologies, bolstering its pipeline of cell therapies designed to combat cancer and autoimmune diseases; the deal is worth approximately US$1.2B

AstraZeneca initiates Phase 2 clinical trial for trastuzumab deruxtecan to treat selected her2-overexpressing tumors; recruitment has not yet started

Sodexo reinforces its contract of Food and Facilities Management Services with AstraZeneca in the UK, Sweden, Denmark, Finland and Norway for a further 5-year period

AstraZeneca initiates Phase 1, 2 clinical trial of AZD0754, a CAR T-cell therapy for metastatic prostate cancer; AstraZeneca to recruit 60 participants in the US

US Patent Issued to AstraZeneca on Feb. 20 for "Methods of treating heart failure with reduced ejection fraction" (Swedish Inventor)

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count